Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131847) titled 'A Single-arm, Prospective Real-world Study of Linaprazan Glurate Capsules in the Treatment of Reflux Esophagitis' on Sept. 7.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The First Affiliated Hospital of Kunming Medical University

Condition: Reflux Esophagitis

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-10-01

Target Sample Size: Experimental group:400;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=338303

Published by HT Digital Content Services with permission from Health Daily Digest...